Loading chat...

CT SB00649

Bill

Official Source

Status

Introduced

1/28/2021

Primary Sponsor

Martin Looney

Click for details

Origin

Senate

2021 General Assembly

AI Summary

  • Prohibits "pay for delay" contracts between name brand and generic pharmaceutical companies
  • "Pay for delay" agreements occur when brand-name drug manufacturers pay generic competitors to delay bringing lower-cost versions to market
  • Aims to preserve patient access to affordable prescription drugs by preventing anti-competitive practices
  • Referred to the Committee on General Law for consideration

Legislative Description

An Act Concerning The Availability Of Generic Pharmaceuticals.

Last Action

Referred to Joint Committee on General Law

1/28/2021

Committee Referrals

General Law1/28/2021

Full Bill Text

No bill text available